Analysts set a price target for PG at $163.50, citing strong earnings and cost-saving initiatives despite recent stock declines.
Procter & Gamble reported Q3 FY2026 core EPS of $1.59, surpassing the $1.55 consensus, while revenue rose 7.4% YoY to $21.23 billion. The company has delivered five consecutive earnings beats, driven by broad-based growth across all segments and regions.
Despite fundamental strength, PG shares trade 14% below their 52-week high of $166.21, pressured by $400M in tariff headwinds and margin compression. The company’s productivity plan aims to save $1.5 billion in cost of goods sold and reduce 7,000 roles by FY2027, reinforcing its defensive positioning.
Analysts set a price target of $163.50 for PG, implying a 14.95% upside from its current $142.24 price as of May 13, 2026. The stock, with a $330.7 billion market cap and a beta of 0.4, remains a consensus buy with 90% confidence.